Bullish Chart Technicals - AcelRx Print E-mail
By Scott Matusow   
Friday, 04 October 2013 14:01

Below, I show the AcelRx (NASDAQ: ACRX) charts and give some commentary why I believe it will hit $12 soon.

  • Chart 1 

 

We can see a tight bullish wedge forming above, where the 50 day and 20 day moving averages have converged. The end of the black box, or second black line is where it appears the stock is headed to soon, representing the $12 level.


I have drawn in where the current price is, a white circle above, where the MACD signal is crossing above the yellow histogram. The closest past pattern representation is marked with the same white circle, and we can see the stock went up signficantly at that time.

With the buyout buzz associated with this stock and the likeliness of a euro partner soon. I feel the stock will break over $14 within 3 months/ AcelRx is de risked with an already submitted NDA, I expect to hear an FDA acceptance of this NDA within 40 days from now. Again. it’s also possible the company will be bought out before then. Almost always, the chart will tell the story of what could be going on “behind the scenes” so to speak. Wise traders and investors pay close attention to chart technicals, as there is a lot of “noise” out there which should be ignored. These chart technicals help us weed through the noise to determine buy and sell points of a stock and its channel. My price target opinion on ACRX is somewhere around $12 within the next week, and $14 before the end of this year.

 




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter